Chemical and Pharmaceutical Bulletin p. 1412 - 1414 (1996)
Update date:2022-09-26
Topics:
Satoh, Masato
Okamoto, Yoshinori
Koshio, Hiroyuki
Ohta, Mitsuaki
Nishida, Akito
Akuzawa, Shinobu
Miyata, Keiji
Mase, Toshiyasu
Semple, Graeme
A series of (3-substituted phenyl)urea analogues of the potent gastrin/cholecystokinin (CCK)-B receptor antagonist YM022 has been prepared. Structure activity relationship studies of this series suggested that a number of analogues retained good in vitro potency for gastrin/CCK-B receptor. In particular, the (3-amino substituted phenyl)urea derivatives (10-12) were more potent inhibitors of pentagastrin-induced gastric acid secretion in rats than YM022 on intraduodenal (i.d.) administration.
View MoreShanghai doly chemical Co.,Ltd
Contact:+86-21-34716221
Address:No.328,WuHe Roard,MinHang,ShangHai China
Contact:86-532-68629711 13780605697
Address:NO 220 YANAN 3 ROAD,(POST ADMINISTRATION BUILDING),QINGDAO,CHINA
Shenyang Mole pharmaceutical Technology Development Co.,Ltd
Contact:+86-24-31204918/13889278616
Address:No.44, wanliutang road, shenhe District of Shenyang
Nantong LiKai Chemical Co.,Ltd
Contact:+86-513-89068669
Address:Jincheng Science Park
JiYi Chemical (Beijing) Co., Ltd.
Contact:+86-10-89385733
Address:Shilou Town of Fangshan District, Beijing
Doi:10.1016/S0957-4166(03)00483-X
(2003)Doi:10.1055/s-2006-944222
(2006)Doi:10.1023/A:1023931428206
(2003)Doi:10.1055/s-1976-24162
(1976)Doi:10.1021/ja00439a074
(1976)Doi:10.1021/jo00427a031
(1977)